Fibular aplasia-ectrodactyly syndrome

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:1118OMIM:113310Q73.8
Who is this for?
Show terms as
8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Fibular aplasia-ectrodactyly syndrome is an extremely rare congenital limb malformation disorder characterized by the combination of absence or severe underdevelopment of the fibula (the smaller bone of the lower leg) and ectrodactyly, which is a split hand/foot malformation sometimes described as 'lobster claw' deformity. The condition primarily affects the skeletal system, specifically the limbs. Patients typically present at birth with bilateral or unilateral absence of the fibula along with missing or fused digits and deep clefts in the hands and/or feet. The lower limbs may be shortened and bowed due to the absent fibula, which can also lead to ankle instability and difficulty with ambulation. The syndrome has been reported in only a small number of families and sporadic cases in the medical literature. Some reported cases suggest autosomal dominant inheritance with variable expressivity, meaning that affected individuals within the same family may show different degrees of severity. The upper and lower limbs can be variably involved, and additional skeletal anomalies may occasionally be present. There is no cure for fibular aplasia-ectrodactyly syndrome. Management is supportive and symptomatic, typically involving a multidisciplinary team including orthopedic surgeons, physical therapists, and prosthetists. Treatment options may include orthopedic surgical interventions such as limb lengthening procedures, corrective osteotomies, or in severe cases, amputation with prosthetic fitting to improve mobility. Reconstructive hand surgery may be considered to improve hand function. Early intervention and rehabilitation are important to optimize functional outcomes and quality of life.

Clinical phenotype terms— hover any for plain English:

Aplasia/Hypoplasia of the fibulaHP:0006492
Inheritance

Autosomal dominant

Passed on from just one parent; each child has about a 50% chance of inheriting it

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

No FDA-approved treatments are currently listed for Fibular aplasia-ectrodactyly syndrome.

View clinical trials →

No actively recruiting trials found for Fibular aplasia-ectrodactyly syndrome at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Fibular aplasia-ectrodactyly syndrome community →

No specialists are currently listed for Fibular aplasia-ectrodactyly syndrome.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Fibular aplasia-ectrodactyly syndrome.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Fibular aplasia-ectrodactyly syndromeForum →

No community posts yet. Be the first to share your experience with Fibular aplasia-ectrodactyly syndrome.

Start the conversation →

Latest news about Fibular aplasia-ectrodactyly syndrome

No recent news articles for Fibular aplasia-ectrodactyly syndrome.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Common questions about Fibular aplasia-ectrodactyly syndrome

What is Fibular aplasia-ectrodactyly syndrome?

Fibular aplasia-ectrodactyly syndrome is an extremely rare congenital limb malformation disorder characterized by the combination of absence or severe underdevelopment of the fibula (the smaller bone of the lower leg) and ectrodactyly, which is a split hand/foot malformation sometimes described as 'lobster claw' deformity. The condition primarily affects the skeletal system, specifically the limbs. Patients typically present at birth with bilateral or unilateral absence of the fibula along with missing or fused digits and deep clefts in the hands and/or feet. The lower limbs may be shortened a

How is Fibular aplasia-ectrodactyly syndrome inherited?

Fibular aplasia-ectrodactyly syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Fibular aplasia-ectrodactyly syndrome typically begin?

Typical onset of Fibular aplasia-ectrodactyly syndrome is neonatal. Age of onset can vary across affected individuals.